- Previous Close
0.0020 - Open
0.0020 - Bid 0.0011 x --
- Ask 0.0052 x --
- Day's Range
0.0020 - 0.0020 - 52 Week Range
0.0001 - 0.3610 - Volume
77,082 - Avg. Volume
6,438 - Market Cap (intraday)
150.984M - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2600 - Earnings Date Apr 29, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. The company offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. It serves healthcare providers. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.
qlinea.comRecent News: 3F8.F
View MorePerformance Overview: 3F8.F
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3F8.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3F8.F
View MoreValuation Measures
Market Cap
150.98M
Enterprise Value
276.52M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.70
Price/Book (mrq)
--
Enterprise Value/Revenue
117.07
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-69.75%
Return on Equity (ttm)
-267.45%
Revenue (ttm)
5.79M
Net Income Avi to Common (ttm)
-216.87M
Diluted EPS (ttm)
-0.2600
Balance Sheet and Cash Flow
Total Cash (mrq)
25.66M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-105.48M